Clinical trial
Concomitant Radiation and Cisplatin With and Without Tirapazamine in Treatment…
NCT00094081 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00094081 |
|---|---|
| Title | Concomitant Radiation and Cisplatin With and Without Tirapazamine in Treatment of Advanced Head and Neck Cancer |
| Official title | Phase III Randomized Trial of Concomitant Radiation, Cisplatin, and Tirapazamine Versus Concomitant Radiation and Cisplatin in Patients With Advanced Head and Neck Cancer |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Head and Neck Neoplasms |
| Intervention type | Drug, Procedure |
| Interventions | tirapazamine (SR259075), cisplatin, Radiation Therapy |
| Enrollment | 861 |
| Start date | Oct 1, 2002 |
| Primary completion | Sep 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Oct 14, 2004 |
| Last update posted | Feb 15, 2010 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: